Novel nanomicelle formulation to enhance bioavailability and stability of curcuminoids

Publish Year: 1397
نوع سند: مقاله ژورنالی
زبان: English
View: 312

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-22-3_010

تاریخ نمایه سازی: 20 مهر 1398

Abstract:

Objective(s): Curcuminoids, comprising curcumin, demethoxycurcumin (DMC) and bisdemethoxycurcumin (BDMC), are bioactive phytochemicals with numerous pharmacological effects. Oral biological availability of curcuminoids is low due to the low aqueous solubility and rapid metabolism. This study aimed at fabricating a nanomicellar curcuminoid formula with enhanced pharmacokinetic properties. Materials and Methods: Curcuminoids nanomicelles were prepared and characterized regarding particle properties, stability, release profile and pharmacokinetic parameters.Results: Encapsulation efficiency of curcuminoids in nanomicelles were 100%. Particle size analysis demonstrated a mean size of around 10 nm that remained stable for 24 months. Dissolution test showed the complete dissolution of encapsulated curcuminoids from nanomicelles within 20 min while the free curcuminoids were poorly dissolved (approximately 7% after 60 min). The results of long-term (24 months) and accelerated (6 months) stability studies showed no changes in the size and content of nanomicelles. The release studies in simulated gastric fluid (SGF) and simulated intestinal fluid (SIF) showed no release of curcuminoids for at least 4 hours. In vivo study in BALB/c mice showed improved pharmacokinetic parameters including maximum plasma concentration (Cmax) and time to reach the maximum concentration (Tmax) with nanomicelles as compared to free curcuminoids and two other commercial products. Tmax for all the three curcuminoid components was observed 30 min following oral administration. AUC of nanomicellar curcuminoids was 59.2 times more than free  curcuminoids. Conclusion: These data indicated that nanomicelles could improve solubility, oral bioavailability and also the stability of curcuminoids. Thus, they merit further investigation for enhancing pharmacological effects of curcuminoids.

Authors

Mahdi Hatamipour

Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran|Department of Medicinal Chemistry, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Amirhossein Sahebkar

Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran|Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Seyedeh Hoda Alavizadeh

Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran|Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Mahyar Dorri

Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran|Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Pulido-Moran M, Moreno-Fernandez J, Ramirez-Tortosa C, Ramirez-Tortosa M. Curcumin and ...
  • Gupta SC, Kismali G, Aggarwal BB. Curcumin, a component of ...
  • Prasad S, Gupta SC, Tyagi AK, Aggarwal BB. Curcumin, a ...
  • Sahebkar A. Are curcuminoids effective C-reactive protein-lowering agents in clinical ...
  • Panahi Y, Sahebkar A, Parvin S, Saadat A. A randomized ...
  • Panahi Y, Hosseini MS, Khalili N, Naimi E, Majeed M, ...
  • Mirzaei H, Naseri G, Rezaee R, Mohammadi M, Banikazemi Z, ...
  • Momtazi AA, Shahabipour F, Khatibi S, Johnston TP, Pirro M, ...
  • Liu W, Zhai Y, Heng X, Che FY, Chen W, ...
  • Dawidczyk C, Kim C, Park J, Russell L, Lee K, ...
  • Mobasheri M, Attar H, Rezayat Sorkhabadi SM, Khamesipour A, Jaafari ...
  • Shakeri A, Sahebkar A. Opinion Paper: Nanotechnology: A Successful Approach ...
  • Patent Cooperation Treaty: 2018 MRJ, curcumin nanomicelles for oral administration, International ...
  • Ahmadi M, Agah E, Nafissi S, Jaafari MR, Harirchian MH, ...
  • Rahimi HR, Mohammadpour AH, Dastani M, Jaafari MR, Abnous K, ...
  • Charbgoo F, Alibolandi M, Taghdisi S, Abnous K, Soltani F, ...
  • Khodaverdi E, Tekie FSM, Mohajeri SA, Ganji F, Zohuri G, ...
  • Gao J, Sun J, Li H, Liu W, Zhang Y, ...
  • Sahay G, Alakhova DY, Kabanov AV. Endocytosis of nanomedicines. J ...
  • Letchford K, Liggins R, Burt H. Solubilization of hydrophobic drugs ...
  • Zhao L, Du J, Duan Y, Zang Y, Zhang H, ...
  • Erfani-Moghadam V, Nomani A, Zamani M, Yazdani Y, Najafi F, ...
  • Sahu A, Kasoju N, Goswami P, Bora U. Encapsulation of ...
  • Hussain N, Jaitley V, Florence AT. Recent advances in the ...
  • Bao Y, Guo Y, Zhuang X, Li D, Cheng B, ...
  • Yodkeeree S, Chaiwangyen W, Garbisa S, Limtrakul P. Curcumin, demethoxycurcumin ...
  • نمایش کامل مراجع